Period Pills for Menstrual Regulation: A New Reproductive Health Option
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexFemale
Age18+
SponsorUniversity of California, San Francisco
About this trial
The Period Pills Study is a prospective observational study among people who decide to use a combination of mifepristone and misoprostol for menstrual regulation.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Be 18 years old or older
Read and speak English
Know the date of their last menstrual period within 2 days
Have a period that is late by up to 21 days
Disqualifiers
Under 18 years old
Does not read and speak English
Does not know the date of their last menstrual period within 2 days
Has not had regular periods in the last 4 months
Trial design
Design model
Single group
Treatments tested in this trial
Mifepristone + Misoprostol
DrugStudy participants are given mifepristone and misoprostol for menstrual regulation.
Treatment groups
100 Participants
are divided into 1 treatment groupGroup A: Study ParticipantsExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Interest in period pills
The proportion of the clinic-going population that may be interested in a period pill to bring on a late period and accept not having their pregnancy confirmed beforehand, therefore not knowing whether they terminated a pregnancy.
Time frame
Documented at Enrollment Survey2
Satisfaction with period pills
The proportion of participants reporting being "satisfied" or "very satisfied" with the period pills on a five-point Likert scale at follow-up (4 weeks).
Time frame
Documented at Follow-up Survey, 4 weeks after drug administrationSecondary outcomes
1
Efficacy of period pills
The proportion of participants that successfully brought down their period, resulting in a negative pregnancy test and the return of their period.
Time frame
Documented at the follow-up visit, through study completion at around 4 weeks after drug administration.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov